# VS Pharmtech Boosts Cancer Treatment Efficacy Without Adding Toxicity

- Source: PR Newswire M&A
- Published: 2026-11-06T17:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/vs-pharmtech-boosts-cancer-treatment-efficacy-without-adding-toxicity-302931942.html
- Canonical: https://groundlevelnews.com/story/vs-pharmtech-boosts-cancer-treatment-efficacy-without-adding-toxicity-2cce42/

SEOUL, South Korea, Nov. 6, 2026 /PRNewswire/ -- Cancer drugs keep improving, but their limits remain. When antibody therapies first emerged, only a fraction of patients benefited, and small-molecule anticancer drugs often carry severe toxicity. Rather than developing a new anticancer...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
